2 , 4 , 12 , 23 , 26 Furthermore, preconception withdrawal of natalizumab increased the odds of relapse during pregnancy, while continuation into the third trimester reduced the odds, although the latter did not reach statistical significance.
← all excerpts
Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis Disability.
1
—
—